Boehringer to Host 29 Presentations on IPF, Other Respiratory Diseases at Annual Thoracic Conference
Idiopathic Pulmonary Fibrosis, News
Boehringer Ingelheim Pharmaceuticals, Inc. has announced that it will participate in the 2015 American Thoracic Society (ATS) International Conference taking place between May 15 and 20 in Denver, and will present 29 abstracts on treatments for respiratory ... Read more